Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
MRNA Therapeutics Market: By Type, By Application, By Distribution Channel, and Geography
1.Executive Summary |
2.Global MRNA Therapeutics Market Introduction |
2.1.Global MRNA Therapeutics Market - Taxonomy |
2.2.Global MRNA Therapeutics Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global MRNA Therapeutics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global MRNA Therapeutics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global MRNA Therapeutics Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
5.1. Prophylactic Vaccines, |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Therapeutic Vaccines, |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Therapeutic Drugs |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global MRNA Therapeutics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
6.1. Rare Genetic Diseases, |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Oncology, |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Respiratory Diseases, |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Infectious Diseases, |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global MRNA Therapeutics Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
7.1. Hospitals & Clinics, |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Research Organizations, |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global MRNA Therapeutics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value US$ Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Prophylactic Vaccines, |
9.1.2.Therapeutic Vaccines, |
9.1.3.Therapeutic Drugs |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Rare Genetic Diseases, |
9.2.2.Oncology, |
9.2.3.Respiratory Diseases, |
9.2.4.Infectious Diseases, |
9.2.5.Others |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals & Clinics, |
9.3.2.Research Organizations, |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
10.1. Type Analysis and Forecast by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Prophylactic Vaccines, |
10.1.2.Therapeutic Vaccines, |
10.1.3.Therapeutic Drugs |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Rare Genetic Diseases, |
10.2.2.Oncology, |
10.2.3.Respiratory Diseases, |
10.2.4.Infectious Diseases, |
10.2.5.Others |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals & Clinics, |
10.3.2.Research Organizations, |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
11.1. Type Analysis and Forecast by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Prophylactic Vaccines, |
11.1.2.Therapeutic Vaccines, |
11.1.3.Therapeutic Drugs |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Rare Genetic Diseases, |
11.2.2.Oncology, |
11.2.3.Respiratory Diseases, |
11.2.4.Infectious Diseases, |
11.2.5.Others |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals & Clinics, |
11.3.2.Research Organizations, |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
12.1. Type Analysis and Forecast by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Prophylactic Vaccines, |
12.1.2.Therapeutic Vaccines, |
12.1.3.Therapeutic Drugs |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Rare Genetic Diseases, |
12.2.2.Oncology, |
12.2.3.Respiratory Diseases, |
12.2.4.Infectious Diseases, |
12.2.5.Others |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals & Clinics, |
12.3.2.Research Organizations, |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value US$ Million) |
13.1. Type Analysis and Forecast by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Prophylactic Vaccines, |
13.1.2.Therapeutic Vaccines, |
13.1.3.Therapeutic Drugs |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Rare Genetic Diseases, |
13.2.2.Oncology, |
13.2.3.Respiratory Diseases, |
13.2.4.Infectious Diseases, |
13.2.5.Others |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals & Clinics, |
13.3.2.Research Organizations, |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value US$ Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Moderna, Inc. |
14.2.2.BioNTech SE |
14.2.3.CureVac N.V. |
14.2.4.Arcturus Therapeutics |
14.2.5.Translate Bio, Inc. |
14.2.6.GSK plc. |
14.2.7.Argos Therapeutics Inc. |
14.2.8.Sangamo Therapeutics, Inc. |
14.2.9.Pfizer Inc. |
14.2.10.AstraZeneca plc. |
14.2.11.Sanofi |
14.2.12.CRISPR Therapeutics AG |
15. Research Methodology |
16. Appendix and Abbreviations |
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The mrna therapeutics market key players are Moderna, Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Translate Bio, Inc.
Key Market Players